Shinichiro Takiguchi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reactive Attachment Disorder | 5 | 2020 | 42 | 0.750 |
Why?
|
| Child Abuse | 8 | 2024 | 1092 | 0.720 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 10 | 2022 | 3742 | 0.490 |
Why?
|
| Methylphenidate | 3 | 2022 | 491 | 0.390 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2019 | 251 | 0.380 |
Why?
|
| Visual Cortex | 3 | 2024 | 1112 | 0.290 |
Why?
|
| Oxytocin | 2 | 2021 | 402 | 0.270 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 2427 | 0.190 |
Why?
|
| Fixation, Ocular | 2 | 2020 | 243 | 0.190 |
Why?
|
| Dyslexia | 1 | 2022 | 215 | 0.180 |
Why?
|
| Attention | 2 | 2020 | 2423 | 0.160 |
Why?
|
| Receptors, Oxytocin | 1 | 2019 | 71 | 0.160 |
Why?
|
| DNA Methylation | 3 | 2023 | 4421 | 0.160 |
Why?
|
| Reading | 1 | 2022 | 543 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2024 | 36840 | 0.150 |
Why?
|
| Child | 24 | 2024 | 80863 | 0.140 |
Why?
|
| Brain | 9 | 2024 | 27438 | 0.140 |
Why?
|
| Theory of Mind | 1 | 2017 | 92 | 0.130 |
Why?
|
| Social Behavior | 3 | 2020 | 1144 | 0.130 |
Why?
|
| Saliva | 1 | 2020 | 854 | 0.120 |
Why?
|
| Japan | 4 | 2022 | 1418 | 0.120 |
Why?
|
| Prefrontal Cortex | 4 | 2019 | 2251 | 0.120 |
Why?
|
| Neostriatum | 1 | 2015 | 247 | 0.120 |
Why?
|
| Thalamus | 1 | 2020 | 1051 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2022 | 1180 | 0.110 |
Why?
|
| Reward | 2 | 2022 | 987 | 0.110 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5827 | 0.110 |
Why?
|
| Retina | 1 | 2024 | 2663 | 0.110 |
Why?
|
| Gait | 1 | 2017 | 822 | 0.090 |
Why?
|
| Organ Size | 3 | 2020 | 2268 | 0.090 |
Why?
|
| Cerebellum | 1 | 2017 | 1515 | 0.080 |
Why?
|
| Nerve Net | 2 | 2024 | 2362 | 0.080 |
Why?
|
| Executive Function | 1 | 2017 | 1402 | 0.080 |
Why?
|
| Adolescent | 13 | 2024 | 89168 | 0.070 |
Why?
|
| Mothers | 1 | 2017 | 2210 | 0.070 |
Why?
|
| Piperidines | 1 | 2015 | 1664 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3826 | 0.060 |
Why?
|
| Sleep | 1 | 2020 | 4796 | 0.060 |
Why?
|
| Male | 19 | 2024 | 364781 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3961 | 0.050 |
Why?
|
| Humans | 26 | 2024 | 768451 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2017 | 6610 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2023 | 505 | 0.050 |
Why?
|
| Female | 17 | 2024 | 396943 | 0.050 |
Why?
|
| Taste Perception | 1 | 2020 | 39 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2020 | 42623 | 0.040 |
Why?
|
| Cognition | 3 | 2022 | 7066 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2024 | 22293 | 0.040 |
Why?
|
| Vestibule, Labyrinth | 1 | 2020 | 235 | 0.040 |
Why?
|
| Depression | 1 | 2017 | 8235 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 956 | 0.040 |
Why?
|
| Emotions | 2 | 2020 | 2773 | 0.030 |
Why?
|
| Intelligence | 1 | 2022 | 929 | 0.030 |
Why?
|
| Anisotropy | 1 | 2020 | 1296 | 0.030 |
Why?
|
| Hearing | 1 | 2020 | 502 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2020 | 588 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 1969 | 0.030 |
Why?
|
| Knee | 1 | 2017 | 279 | 0.030 |
Why?
|
| Cues | 1 | 2020 | 884 | 0.030 |
Why?
|
| Judgment | 1 | 2016 | 273 | 0.030 |
Why?
|
| Genotype | 2 | 2019 | 13047 | 0.030 |
Why?
|
| Morals | 1 | 2016 | 289 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2015 | 298 | 0.030 |
Why?
|
| Ankle | 1 | 2017 | 354 | 0.030 |
Why?
|
| Polysomnography | 1 | 2020 | 1864 | 0.030 |
Why?
|
| Empathy | 1 | 2017 | 476 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 1516 | 0.030 |
Why?
|
| Pelvis | 1 | 2017 | 737 | 0.020 |
Why?
|
| Postural Balance | 1 | 2017 | 638 | 0.020 |
Why?
|
| Students | 1 | 2022 | 1751 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 771 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2015 | 752 | 0.020 |
Why?
|
| Affect | 1 | 2017 | 1498 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2015 | 1427 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2020 | 3122 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 1009 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2015 | 2268 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12450 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4041 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10601 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 7134 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15965 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4636 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8730 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 60045 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18478 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2015 | 6740 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 16029 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2015 | 4538 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 36497 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39430 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 223542 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74915 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65409 | 0.000 |
Why?
|